Ann: Sales Update for Q4 FY2024, page-23

Stryker sell the Hi-Rise unit for $410,000 in the US Market and CVB sells to Stryker for $360,000 in which CVB makes 50% Gross Profit - with recurring revenue of $25000-$30'000 in service charges.This technology is first to market opportunity with a targeted 10 Billion US Market and 2.7 Billion - (SAAS) CVB AI Platform .
With the implications of the stream line created by in-house bone density tests ( one patient visit) this is compelling IMHO from my medical background with Doctors re- enbursments $240 Cat Scan - $140 Bone Density Test.
Harvard,Penn,UCLA,HSS are hospitals already using the Hi-Rise with Stryker moving on the group surgeon medical centre which will follow the the US Hospitals success.
The FDA approval this week for the full - body scan is very exciting and it's potential IMHO